Tipranavir (TPV) genotypic Inhibitory Quotient (gIQ) predicts Virological Response at 48 weeks to TPV-based salvage regimens

DE REQUENA DG; S BONORA; Andrea CALCAGNO; A D'AVOLIO; M SICCARDI; S FONTANA; MILIA MG; M SCIANDRA; S GARAZZINO; GARBO A DI; L BAIETTO; L TRENTINI; PERRI G DI

Tipranavir (TPV) genotypic Inhibitory Quotient (gIQ) predicts Virological Response at 48 weeks to TPV-based salvage regimens

DE REQUENA DG, S BONORA, Andrea CALCAGNO, A D'AVOLIO, M SICCARDI, S FONTANA, MILIA MG, M SCIANDRA, S GARAZZINO, GARBO A DI, L BAIETTO, L TRENTINI, PERRI G DI

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista

Lingua originale	Inglese
Rivista	Antimicrobial Agents and Chemotherapy
Stato di pubblicazione	Pubblicato - 2007

Accesso al documento

https://hdl.handle.net/11579/216839

Altri file e collegamenti

handle

Cita questo

DG, DE. REQUENA., BONORA, S., CALCAGNO, A., D'AVOLIO, A., SICCARDI, M., FONTANA, S., MG, MILIA., SCIANDRA, M., GARAZZINO, S., DI, GARBO. A., BAIETTO, L., TRENTINI, L., & DI, PERRI. G. (2007). Tipranavir (TPV) genotypic Inhibitory Quotient (gIQ) predicts Virological Response at 48 weeks to TPV-based salvage regimens. Antimicrobial Agents and Chemotherapy. https://hdl.handle.net/11579/216839

@article{d02a4b1293d34f4295c7a15c7dda468a,

title = "Tipranavir (TPV) genotypic Inhibitory Quotient (gIQ) predicts Virological Response at 48 weeks to TPV-based salvage regimens",

author = "DG, \{DE REQUENA\} and S BONORA and Andrea CALCAGNO and A D'AVOLIO and M SICCARDI and S FONTANA and MILIA MG and M SCIANDRA and S GARAZZINO and DI, \{GARBO A\} and L BAIETTO and L TRENTINI and DI, \{PERRI G\}",

year = "2007",

language = "English",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

}

DG, DEREQUENA, BONORA, S, CALCAGNO, A, D'AVOLIO, A, SICCARDI, M, FONTANA, S, MG, MILIA, SCIANDRA, M, GARAZZINO, S, DI, GARBOA, BAIETTO, L, TRENTINI, L & DI, PERRIG 2007, 'Tipranavir (TPV) genotypic Inhibitory Quotient (gIQ) predicts Virological Response at 48 weeks to TPV-based salvage regimens', Antimicrobial Agents and Chemotherapy. <https://hdl.handle.net/11579/216839>

TY - JOUR

T1 - Tipranavir (TPV) genotypic Inhibitory Quotient (gIQ) predicts Virological Response at 48 weeks to TPV-based salvage regimens

AU - DG, DE REQUENA

AU - BONORA, S

AU - CALCAGNO, Andrea

AU - D'AVOLIO, A

AU - SICCARDI, M

AU - FONTANA, S

AU - MG, MILIA

AU - SCIANDRA, M

AU - GARAZZINO, S

AU - DI, GARBO A

AU - BAIETTO, L

AU - TRENTINI, L

AU - DI, PERRI G

PY - 2007

Y1 - 2007

UR - https://iris.uniupo.it/handle/11579/216839

M3 - Article

SN - 0066-4804

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

ER -